description1
Product Description
Eptifibatide GMP DMF grade is a high-purity synthetic peptide produced under stringent pharmaceutical manufacturing standards. It selectively binds to the platelet glycoprotein IIb/IIIa receptor, effectively preventing fibrinogen cross-linking and platelet aggregation. The product exhibits excellent purity, stability, and batch-to-batch consistency, making it a reliable active pharmaceutical ingredient for acute cardiovascular therapeutics.
Attributes
| English Name | Eptifibatide | Density | < N/A (lyophilized powder) |
| CAS NO | 148031-34-9 | Stability | Stable in lyophilized state (sealed, -20℃ to -80℃); avoid repeated freeze-thaw cycles, strong oxidants, and extreme pH conditions |
| Molecular Formula | C₃₅H₄₉N₁₁O₉S₂ | Storage Condition | Sealed, light-proof, and moisture-proof; store at -20℃ to -80℃ in GMP-compliant facilities |
| Mol.wt. | 831.96 | Solubility | Highly soluble in water (≥25 mg/mL at 25℃), slightly soluble in methanol, insoluble in ether |
| EINECS No. | N/A | Form | Powder |
| MDL No. | MFCD00867577 | Colour | White to off-white lyophilized powder |
| Melting Point | Decomposes above 220℃ (lyophilized form) | pH Value | 4.5-6.5 (0.5% aqueous solution) |
Effective Antiplatelet Action
Provides rapid and reversible inhibition of platelet aggregation by specifically blocking fibrinogen binding to GP IIb/IIIa receptors.
Acute Coronary Syndrome Management
Reduces thrombotic complications in patients with acute coronary syndromes, including unstable angina and non-ST-elevation myocardial infarction.
PCI Support
Minimizes ischemic complications during and after percutaneous coronary interventions (PCI) by preventing acute platelet-mediated thrombosis.
01
Hospital Critical Care
Essential component in emergency cardiovascular care protocols for preventing acute thrombotic events.
01
Cardiovascular Therapeutics
Primary API for injectable solutions used in acute coronary syndrome management and PCI adjunctive therapy.
03
Antithrombotic Research
Reference standard for developing novel antiplatelet agents and combination antithrombotic therapies.
0102030405060708

About Us
Shaanxi Bieyouth Biotech Co., Ltd. is proud to offer Eptifibatide, a cutting-edge supplement for those seeking to enhance their cellular health and protect against the ravages of time. By incorporating our Eptifibatide into your health regimen, you are taking a proactive step towards safeguarding your body's cells and promoting a longer, healthier life. Experience the power of this elite antioxidant and embrace the benefits of Eptifibatide for your well-being.






Whatsapp
WeChat
